Skip to main content

15 – 16 June 2020. —

We are pleased to invite you to join us for the ELSI Virtual Forum, an online meeting on June 15 and 16, 2020, being held in place of the 5th ELSI Congress, now scheduled for March 2021. The Forum will include eight keynote, plenary and panel presentations over the two days, each followed by a half-hour Q&A – we look forward to an enriching discussion!

Attending the ELSI Virtual Forum is free, but registration is required. To register, please create or log in to your Ex Ordo account at For organizing purposes, we appreciate your registering by June 10, 2020.

The program starts at 10:00 AM and ends at 4:30 PM EDT (GMT-4) each day and includes the following sessions:

Keynote and Plenary Talks

  • Integrating ELSI and Genomics: Past, Present, and Future
  • Polygenic Risk Scores & Behavioral Traits: Interrogating the Science & Ethics
  • CRISPR and Human Identity: Governing Germline Gene Editing
  • Ethical Frameworks for Research Collaboration with Indigenous Communities

Panel Presentations

  • Studying America’s Eugenics Era through an ELSI Lens: Data, Context, and Relevance
  • New Models for Ethical AI in Precision Medicine: Empirical and Normative ELSI Inquiry
  • Engaging Participants as Partners: ELSI Considerations in Large-Scale Precision Medicine Research
  • To Catch a Killer: Law Enforcement Uses of DNA Databases

We regret that the pandemic prohibits holding the ELSI Congress at this time. To support information exchange and professional networking among the ELSI research community, we are planning for the next ELSI Congress to take place in March 2021, instead of delaying to 2022 as originally scheduled. More information about ELSIcon2021 and the new call for abstracts will be forthcoming.

As the COVID-19 pandemic continues to disrupt our world and daily lives in so many ways, we hope you and your families remain well and keep safe.

We look forward to seeing you at the ELSI Virtual Forum!


Co-Directors of the Biennial ELSI Congress and the ELSI Virtual Forum

Sandra Soo-Jin Lee, PhD, Chief, Division of Ethics, Department of Medical Humanities and Ethics, Columbia University

Mildred Cho, PhD, Associate Director, Stanford Center of Biomedical Ethics, Stanford University